Psychedelic Sixties

The Psychedelic Sixties is less a precise historical period than a powerful story about psychedelic drugs: Timothy Leary becomes their defining public figure, and the turbulent decade appears to mark both the birth and the death of serious research. The book argues that this familiar frame distorts the chronology. Leary mattered, but the history began before his Harvard project and continued after his dismissal and the public backlash. Recovering that longer arc changes the era from a self-contained countercultural spectacle into one dramatic, consequential chapter in a broader history of research and therapy.

The Icon and the False Beginning

Leary’s public image helped make him seem synonymous with psychedelics. After receiving advice to use his public appearances to reassure rather than alarm, he cultivated a conspicuous camera-facing smile. He maintained it in settings that seemed to contradict one another: outside a courthouse, among youthful admirers in love beads and white robes, and while handcuffed beside a squad car. The image was memorable; it also helped compress a complicated history around a single personality.

The chronology seems to support that compression at first glance. Leary launched the Harvard Psilocybin Project in the fall of 1960, after his first life-changing psilocybin experience in Mexico, and was dismissed from Harvard in 1963. But those dates do not mark the start and finish of serious psychedelic research. Work had already developed during the preceding decade in Saskatchewan, Vancouver, California, England, and elsewhere. The Harvard project was not the first flowering of the field; in the book’s account, it came near the beginning of the end of a particularly fertile earlier period.

The Research the Story Leaves Out

The scale of the earlier work is one measure of what the popular story conceals. Stephen Ross, a psychiatrist specializing in addiction, encountered accounts of LSD treatment for thousands of alcoholics in Canada and the United States while preparing to direct an NYU trial involving psilocybin and cancer-related existential distress. His subsequent research led him to a largely forgotten clinical literature: estimates cited in the book describe about 40,000 research participants and more than 1,000 clinical papers. Psychedelics had been investigated for conditions including addiction, depression, obsessive-compulsive disorder, schizophrenia, autism, and end-of-life anxiety; six international scientific meetings on the subject took place between 1950 and 1965.

This recovery unsettles the neat division between responsible science before Leary and reckless counterculture after him. The early work had involved clinicians, scientists, and committed amateurs who developed ways to understand these unusual substances and protocols for using them therapeutically. Some later watched with alarm as Leary’s stunts and public pronouncements helped turn the subject into a cultural flashpoint. His importance is therefore double: he helped make psychedelics visible, while the story built around his visibility pushed other people’s work and the field’s earlier foundations out of view.

Public Rupture, Continuing Disagreement

The book does not simply replace a heroic Leary narrative with a villainous one. At a 1979 reunion at Oscar Janiger’s home in Los Angeles, first-wave researchers—including Humphry Osmond, Sidney Cohen, Myron Stolaroff, Willis Harman, and Leary—looked back on a project they believed had been badly damaged. Stolaroff directly raised the group’s concern that Leary’s actions had made legitimate research harder to continue. Leary answered that he had understood himself to be playing a different role: by going further out, he gave researchers at Spring Grove room to appear responsible by contrast. Cohen accepted the possibility that the movement had needed both boundary-pushing figures and more cautious investigators, while Osmond resisted reducing the history to a simple verdict of mistake or blame.

The reunion preserves a disagreement that the standard Sixties story tends to flatten. Leary’s account of complementary roles offered one way to interpret the researchers’ conflicting strategies, not proof that everyone agreed or that the consequences were harmless. Their conversation instead shows people trying, years later, to understand how public transgression and clinical respectability interacted—and how much the historical record could not be reduced to a clean division between heroes and villains.

The Afterlife of the Sixties

The end of visible, sanctioned research did not mean that psychedelic therapy vanished. As the work moved underground, later guides continued practices descended from therapists and researchers active on the West Coast and around Cambridge in the 1950s and 1960s. Their professional lineages often ran through Leary, Stanislav Grof, Al Hubbard, or Leo Zeff. The continuity was real, even where the practice itself remained illegal: the guides interviewed for the book asked that their names, locations, and other identifying details be changed, and the author emphasizes that they were real people rather than composites.

That hidden continuation gives the Psychedelic Sixties a less conclusive ending than its public mythology suggests. In the book’s historical method, setting aside the Leary saga until its proper place in the larger account is not a denial of his influence; it is a way to see what his fame has obscured. The decade remains a turning point, but not a beginning without antecedents or an ending without survivors. Its most important legacy is also a warning about historical visibility: the figure who dominates the story can illuminate an era and, at the same time, make much of its substance harder to see.